KOPRANUpdated 1 Sept 2026, 6:40

Kopran Ltd

KOPRANUpdated 1 Sept 2026, 6:40

Market Cap

₹1,052Cr.

Current Price

₹218

High / Low

₹235/107

Stock P/E

31.3

ROE6.91%

ROCE9.19%

Book Value₹92.8

Face Value₹10.0

Dividend Yield1.38%

About

Kopran Ltd. is a fully integrated pharmaceutical company that manufactures and supplies high-quality formulations and active pharmaceutical ingredients globally.

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	33	38	77	48	83	86	81	106	112	95	124	158
Inventory Days	24	90	84	119	78	149	73	119	98	78	129	141
Days Payable	63	114	120	115	101	114	106	85	128	82	108	162
Cash Conversion Cycle	-6	14	41	52	60	121	48	139	82	91	145	137
Working Capital Days	124	41	46	49	59	59	64	129	116	104	114	109
ROCE %	11%	10%	10%	5%	9%	8%	14%	6%	9%	11%	9%	9%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 6:40

KOPRAN LTD (KOPRAN) financials — quarterly results, P&L, cash flow, balance sheet, shareholding